SEC Form D · filed June 23, 2021
ArriVent Biopharma, Inc
Offering
$90.0M
Sold
$81.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEWTOWN SQUARE, PA
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (2)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗